Morepen Laboratories Ltd Quarterly Results

Gross Sales

452.78

437.73

455.22

423.07

444.55

Excise Duty

0

0

0

0

0

Net Sales

452.78

437.73

455.22

423.07

444.55

Other Operating Income

0

0

0

0

0

Other Income

5.34

4.99

3.43

4.24

4.07

Total Income

458.12

442.71

458.64

427.32

448.62

Total Expenditure

417.27

393.66

403.6

374.69

393.99

PBIDT

40.85

49.06

55.05

52.62

54.64

Interest

1.34

1.18

1.15

0.8

2.17

PBDT

39.51

47.88

53.89

51.83

52.47

Depreciation

4.3

1.86

5.73

9.62

8.45

Minority Interest Before NP

0

0

0

0

0

Tax

8.52

11.17

12

13.9

12.03

Deferred Tax

0

0

0

-0.44

0

Reported Profit After Tax

26.69

34.85

36.17

28.74

31.99

Minority Interest After NP

0

0

0

0.46

0

Net Profit after Minority Interest

26.69

34.85

36.17

28.28

31.99

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

26.69

34.85

36.17

28.28

31.99

EPS (Unit Curr.)

0.49

0.65

0.71

0.54

0.63

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

109.58

109.58

102.23

102.23

102.23

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

9.02

11.2

12.09

12.43

12.29

PBDTM(%)

8.72

10.93

11.83

12.25

11.8

PATM(%)

5.89

7.96

7.94

6.79

7.19